Farther Finance Advisors’s Mersana Therapeutics MRSN Stock Holding History

Farther Finance Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Hold	0	–	–	–	5035
2025 Q2	–	Hold	0	–	–	–	4616
2025 Q1	–	Hold	0	–	–	–	4380
2024 Q4	–	Hold	0	–	–	–	3996
2024 Q3	–	Hold	0	–	–	–	3980
2024 Q2	–	Hold	0	–	–	–	3808
2024 Q1	–	Hold	0	–	–	–	3581
2023 Q4	–	Hold	0	–	–	–	3542

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return